Apr 6, 2026 Clinical Lab Products: DecisionDx-Melanoma Gene Expression Test Improves Risk Prediction Beyond Standard Staging
Apr 3, 2026 The Dermatology Digest: Moving Beyond Staging Alone in Melanoma: GEP Testing Refines Mortality Risk
Apr 2, 2026 STAT News: Beyond detection: In the age of clinical AI, what counts as an FDA ‘breakthrough’ medical device?
Apr 1, 2026 GastroGirl Podcast: GERD to Barrett’s Esophagus: A Patient Story that Could Change Your Care
Apr 1, 2026 Genetic Engineering & Biotechnology News: Spatial Biology: From Spatial Transcriptomics to Breakthroughs in Patient Care
Mar 29, 2026 Dermatology Times: Precision and Progress: Key Updates in Skin Cancer Prevention, Diagnosis, and Management
Mar 27, 2026 Gene Online: Castle Biosciences Study Shows DecisionDx-Melanoma Test Enhances Risk Prediction Within AJCC Staging System
Mar 16, 2026 Targeted Oncology: Prospective Data Support i31-SLNB Test to Guide Biopsy Use in Melanoma
Mar 13, 2026 Practical Dermatology: From Diagnosis to Prognosis: Using MyPath® Melanoma and DecisionDx®-Melanoma to Help Guide Patient Management Decisions
